Amoxicillin-clavulanate–induced neurotoxicity in a patient with end-stage renal disease: a case of reversible encephalopathy
- 1Jefferson Abington Hospital, Abington, PA USA
Abstract
Beta-lactam antibiotics are a known but under-recognized cause of neurotoxicity, particularly in patients with renal impairment. While cefepime-associated neurotoxicity is well-described, less attention has been given to amoxicillin–clavulanate. We present a case of a 67-year-old male with end-stage renal disease (ESRD) on chronic intermittent hemodialysis for more than 5 years via a left upper extremity arteriovenous fistula who developed acute encephalopathy characterized by agitation, confusion, and fluctuating consciousness shortly after initiation of 875/125 mg amoxicillin–clavulanate twice daily following hospital discharge. Symptoms began approximately 48 h after antibiotic initiation after the patient had received approximately five total doses, including doses taken before and after a shortened outpatient dialysis session. Symptoms resolved after discontinuation of the medication and completion of inpatient hemodialysis. Extensive workup, including neuroimaging and electroencephalography, was unrevealing. Infectious and metabolic etiologies were excluded based on clinical evaluation and specialist consultation. This case highlights the importance of recognizing antibiotic-induced neurotoxicity in patients with ESRD and emphasizes the risks of inappropriate outpatient dosing at hospital discharge.
Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s13256-026-06389-x.
Related
- Population pharmacokinetics of child-friendly dispersible amoxicillin/clavulanate tablets in African children with severe community acquired pneumonia
- Pregnancy-Induced Hypertension Complicated by Posterior Reversible Encephalopathy Syndrome: A Case Series of Two Patients.
- Clinical and radiological features of posterior reversible encephalopathy syndrome in children: a retrospective study
- When Posterior Reversible Encephalopathy Syndrome is Not Posterior: An Atypical Pediatric Presentation
- Occult Multiple Arterial Occlusions in Behçet’s Disease Manifesting as Posterior Reversible Encephalopathy Syndrome Secondary to Renovascular Hypertension
BibTeX
@article{walz2026amoxicillinclavulanateinduced,
title = {{Amoxicillin-clavulanate–induced neurotoxicity in a patient with end-stage renal disease: a case of reversible encephalopathy}},
author = {David J. Walz and Nimra Klair and Noelle Pennacchia and Ho An Lau and Temitope Omoladun-Tijani},
journal = {Journal of Medical Case Reports},
year = {2026},
month = jul,
doi = {10.1186/s13256-026-06389-x},
url = {https://doi.org/10.1186/s13256-026-06389-x},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Amoxicillin-clavulanate–induced neurotoxicity in a patient with end-stage renal disease: a case of reversible encephalopathy
AU - David J. Walz
AU - Nimra Klair
AU - Noelle Pennacchia
AU - Ho An Lau
AU - Temitope Omoladun-Tijani
PY - 2026
DA - 2026/07/31
JO - Journal of Medical Case Reports
DO - 10.1186/s13256-026-06389-x
UR - https://doi.org/10.1186/s13256-026-06389-x
AB - Beta-lactam antibiotics are a known but under-recognized cause of neurotoxicity, particularly in patients with renal impairment. While cefepime-associated neurotoxicity is well-described, less attention has been given to amoxicillin–clavulanate. We present a case of a 67-year-old male with end-stage renal disease (ESRD) on chronic intermittent hemodialysis for more than 5 years via a left upper extremity arteriovenous fistula who developed acute encephalopathy characterized by agitation, confusion, and fluctuating consciousness shortly after initiation of 875/125 mg amoxicillin–clavulanate twice daily following hospital discharge. Symptoms began approximately 48 h after antibiotic initiation after the patient had received approximately five total doses, including doses taken before and after a shortened outpatient dialysis session. Symptoms resolved after discontinuation of the medication and completion of inpatient hemodialysis. Extensive workup, including neuroimaging and electroencephalography, was unrevealing. Infectious and metabolic etiologies were excluded based on clinical evaluation and specialist consultation. This case highlights the importance of recognizing antibiotic-induced neurotoxicity in patients with ESRD and emphasizes the risks of inappropriate outpatient dosing at hospital discharge. Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s13256-026-06389-x.
SN - 1752-1947
ER -